Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
EuroAPI develops, manufactures and supplies the active-ingredient solutions for healthcare.
Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Atropos Health develops a clinical analytics platform that specializes in evidence-based healthcare.
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
Empatica is an affective computing company focused on human data analytics.
Portal Instruments is an early stage company that offers medical device.
Health tech company using clinical trial simulation technology to predict drug efficacy and optimize clinical trial development.
Sanofi has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, EuroAPI received $825.5M in a Post Ipo Debt round. Sanofi's total known invested capital is $5.5B.
Sanofi's average investment size is $112.3M across its portfolio of 129 companies.
Recent Sanofi portfolio additions include AgomAb Therapeutics, EuroAPI, Nura Bio, Vigil Neuroscience, Atropos Health. These companies were founded in 2020 or later.